1. Inicio
  2. Proyectos y Estudios
  3. LIFECHAMPS.

LIFECHAMPS.

Datos básicos

Código:
875329
Protocolo:
875329
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
298.750,00 €
Año de incio:
2019
Año de finalización:
2023
PI BIOMÉDICA EUROPEA Finan. Competitiva Pública

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

COMISION EUROPEA

Resultados del Ensayo Clínico

A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

de la Fuente, Ana; (...); Ravassa, Susana

Article. 10.3390/cancers14122941. 2022


A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)

Llombart-Cussac, A; (...); Albanell, J

Meeting Abstract. 2021


A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond six cycles in patients with glioblastoma (GEINO 14-01).

Balana C; (...); Carrato C

Article. 10.1093/neuonc/noaa107. 2020


A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.

Papachristou, Nikolaos; (...); Bamidis, Panagiotis D.

Article. 10.1016/j.soncn.2023.151437. 2023


A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain.

Giménez-Campos MS; (...); Ruíz-García V

Article. 10.1016/j.aprim.2021.102144. 2021


Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.

Battisti NML; (...); Wildiers H

Review. 10.1016/j.jgo.2020.07.008. 2020


Addressing the challenges of cancer care in older adults: The unique benefits of oncogeriatric evaluation and management.

Martinez-Peromingo, Javier; (...); Girones, Regina

Letter. 10.1016/j.regg.2023.03.002. 2023


Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020


Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Garrido Siles, Marga; (...); Angel Climent, Miguel

Review. 10.3390/cancers14163968. 2022


ANALYSIS OF THE CLINICAL EXPERIENCE WITHIN RUCAPARIB'S EARLY ACCESS PROGRAM IN SPAIN - A GEICO STUDY

Yubero-Esteban, A.; (...); Gonzalez-Martin, A.

Meeting Abstract. 10.1136/ijgc-2021-ESGO.398. 2021


Analytical exploratory tool for healthcare professionals to monitor cancer patients' progress.

Valero-Ramon, Zoe; (...); Traver, Vicente

Article. 10.3389/fonc.2022.1043411. 2022


Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.

Perez-Fidalgo, Jose Alejandro; (...); Gonzalez-Martin, Antonio

Article. 10.1136/ijgc-2022-004028. 2023


Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO.

Yubero-Esteban, Alfonso; (...); Sanchez Lorenzo, Maria Luisa

Meeting Abstract. 2022


Clinical insights from the rucaparib access program in Spain: A sub-analysis of long-term responders by GEICO.

Yubero-Esteban, Alfonso; (...); Gonzalez Martin, Antonio

Meeting Abstract. 2022


COVID-19 and hospitalised cancer patients: Now it's time for patients to talk

Arrue, BD; (...); Sarrio, RG

Meeting Abstract. 10.1016/j.annonc.2020.08.2061. 2020


Characterization of the gene expression profile of breast cancer tumours in patients undergoing ovarian stimulation for fertility preservation purposes

Soriano, M. J.; (...); Diaz-Garcia, C.

Meeting Abstract. 2022


Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

Sarrio, RG; (...); Porta-Sales, J

Article. 10.1186/s12904-020-00693-z. 2021


Design of 1-year mortality forecast at hospital admission: A machine learning approach.

Blanes-Selva V; (...); García-Gómez JM

Article. 10.1177/1460458220987580. 2021


Development and validation of an early death risk score for older patients treated with chemotherapy for cancer.

Batlle, JF; (...); Molina-Garrido, MJ

Meeting Abstract. 2020


Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer

Feliu, J; (...); Molina-Garrido, MJ

Article. 10.3390/jcm10081615. 2021


Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

Rubio, MJ; (...); Santaballa, A

Article. 10.1016/j.gore.2020.100594. 2020


Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis.

Angeles Vaz, Maria; (...); De Las Penas Bataller, Ramon

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14046. 2021


Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer

Loras, A, Segovia, C, Ruiz-Cerda, JL

Review. 10.3390/cancers13112719. 2021


Evaluation design of the patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard (InAdvance): a randomised controlled trial.

Yang-Huang, Junwen; (...); Raat, Hein

Article. 10.1186/s12877-022-03508-3. 2022


Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project

Torregrosa, MD; (...); Ruiz, A

Article. 10.1007/s12094-019-02189-6. 2019


Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma

Villar, MV; (...); Santos, JD

Meeting Abstract. 10.1016/j.annonc.2021.08.008. 2021


Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer.

Torregrosa-Maicas MD; (...); Gironés-Sarrió R

Article. 10.1007/s12094-021-02766-8. 2022


GEICO1601-ROLANDO trial: A multicentric single arm phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

Fidalgo, JAP; (...); Martin, AG

Meeting Abstract. 10.1016/j.annonc.2020.08.971. 2020


Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).

Elez E; (...); Garrido P

Article. 10.1016/j.esmoop.2021.100048. 2021


Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601).

Alejandro Perez-Fidalgo, Jose; (...); Gonzalez-Martin, Antonio

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.5549. 2021


Identification of a specific epigenetic signature in patients showing secondary hypertension upon anti-VEGF treatment from the GEICAM/2011-04 (BRECOL) study

de la Haba, J; (...); Rodriguez-Lescure, A

Meeting Abstract. 10.1158/1538-7445.SABCS19-P4-10-28. 2020


Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer

Salvador-Coloma, C; (...); de Mora, JF

Article. 10.1016/j.ejca.2020.08.020. 2020


Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.

Vaz Salgado, Maria Angeles; (...); De Las Penas Bataller, Ramon

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14047. 2021


In memoriam of Ricardo Flores: The career, achievements, and legacy of an inspirational plant virologist.

Pallas, Vicente; (...); Moreno, Pedro

Article. 10.1016/j.virusres.2022.198718. 2022


Lack of integration, staff burden or time constraints as barriers to the implementation of an early palliative care intervention

Donate-Martinez, Ascension; (...); Garces, Jorge

Meeting Abstract. 10.5334/ijic.ICIC22205. 2022


Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

Lee, CH; (...); Motzer, JR

Article. 10.1016/S1470-2045(21)00241-2. 2021


Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study.

Longo-Munoz, Federico; (...); Subbiah, Vivek

Article. 10.1016/j.ejca.2022.06.024. 2022


Multidisciplinary consensus on the criteria for fertility preservation in cancer patients.

Santaballa, A.; (...); Manau-Trullas, D.

Article. 10.1007/s12094-021-02699-2. 2022


Neutrophil-lymphocyte ratio predicts survival in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD): Stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601

Fidalgo, JAP; (...); Gonzalez-Martin, A

Meeting Abstract. 10.1016/j.annonc.2021.08.1177. 2021


NIRAPARIB AS MAINTENANCE THERAPY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A GEICO STUDY WITHIN THE SPANISH EXTENDED ACCESS PROGRAM

Cueva Banuelos, J. F.; (...); Gonzalez-Martin, A.

Meeting Abstract. 10.1136/ijgc-2021-ESGO.447. 2021


Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Perez-Fidalgo, JA; (...); Gonzalez-Martin, A

Article. 10.1016/j.esmoop.2021.100212. 2021


Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.

Garcia-Donas, Jesus; (...); Grande, Enrique

Article. 10.1007/s12094-023-03085-w. 2023


OReO/ENGOT Ov-38 trial: Impact of maintenance olaparib rechallenge according to ovarian cancer patient prognosis-An exploratory joint analysis of the BRCA and non-BRCA cohorts.

Selle, Frederic; (...); Pujade-Lauraine, Eric

Meeting Abstract. 2022


Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.

Martin, Miguel; (...); Gil-Gil, Miguel

Article. 10.1016/j.ejca.2022.03.006. 2022


Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.

Aparicio, J.; (...); Germa, J. R.

Article. 10.1007/s12094-020-02393-9. 2021


Phase II trial evaluating olaparib maintenance in patients with metastatic castration resistant prostate cancer (mCRPC) after docetaxel treatment, reaching partial or stable response: SOGUG-IMANOL study.

Juan Fita, Maria Jose; (...); Heras, Lucia

Meeting Abstract. 2023


Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.

Garcia del Muro, Xavier; (...); Vigues, Francesc

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.4505. 2021


Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy as bladder-sparing therapy in patients with localized muscle invasive bladder cancer: A SOGUG study.

Cuellar, M. Andres; (...); Garcia del Muro, Xavier

Meeting Abstract. 2020


Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell renal cell carcinoma (mccRCC).

Lee, CH; (...); Motzer, RJ

Meeting Abstract. 2020


Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for progressive disease after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell (mcc) renal cell carcinoma (RCC): Results by independent imaging review and subgroup analyses

Lee, CH; (...); Motzer, RJ

Meeting Abstract. 10.1016/j.annonc.2020.08.782. 2020


Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients

Duran, MAC; (...); Nunez, NF

Meeting Abstract. 10.1016/j.annonc.2020.08.2074. 2020


Plk1 expression & efficacy of palbociclib in advanced hormonal receptor-positive breast cancer patients from PEARL study (GEICAM 2012-03)

Guerrero-Zotano, A; (...); Martin, M

Meeting Abstract. 2021


Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.

Girones, Regina, Arnal, Maria, Forcano, Silvia

Meeting Abstract. 2023


Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2-endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study

Tibau, A; (...); Albanell, J

Meeting Abstract. 10.1016/j.annonc.2021.03.108. 2021


Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.

Tibau, Ariadna; (...); Albanell, Joan

Article. 10.1177/17588359221148921. 2023


Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).

Albanell, J.; (...); Rojo, F.

Article. 10.1016/j.ejca.2021.11.010. 2022


Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

Harter P; (...); du Bois A

Article. 10.1056/NEJMoa2103294. 2021


Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)

Redondo, Andres; (...); Gonzalez-Martin, Antonio

Article. 10.31083/j.ejgo4206163. 2021


Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Cueva, Juan F.; (...); Gonzalez-Martin, Antonio

Article. 10.1016/j.ejca.2022.12.023. 2022


Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.

Alvarez-Lopez I; (...); Santaballa Bertrán A

Review. 10.1007/s12094-019-02269-7. 2020


Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program.

Yubero, Alfonso; (...); Gonzalez-Martin, Antonio

Case Reports. 10.1016/j.gore.2023.101211. 2023


Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study

Yubero, Alfonso; (...); Gonzalez-Martin, Antonio

Article. 10.1186/s12885-022-10191-5. 2022


Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

Vaz, Maria Angeles; (...); Martinez-Garcia, Maria

Meeting Abstract. 2022


SEOM clinical guideline for secondary prevention (2019).

Santaballa A; (...); Bayo J

Article. 10.1007/s12094-020-02302-0. 2020


SEOM-GEICO clinical guidelines on endometrial cancer (2021).

Barretina-Ginesta MP; (...); Rubio-Pérez MJ

Article. 10.1007/s12094-022-02799-7. 2022


SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).

Martínez-García M; (...); Manuel Sepúlveda-Sánchez J

Article. 10.1007/s12094-022-02803-0. 2022


Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).

Lopez-Tarruella S; (...); Carrasco E

Article. 10.1038/s41598-019-55765-9. 2019


Survival, quality of life (QoL) and geriatric outcomes of elderly patients (pt) with advanced non-small cell lung cancer (NSCLC), treated with pembrolizumab (P) in the first-line setting

Blanco, R; (...); Vidal, OJJ

Meeting Abstract. 10.1016/j.annonc.2020.08.1631. 2020


The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer.

Mislang AR; (...); Battisti NML

Letter. 10.1016/j.jgo.2021.03.003. 2021


Undertreatment and overtreatment in older patients treated with chemotherapy.

Feliu J; (...); Molina-Garrido MJ

Article. 10.1016/j.jgo.2020.10.010. 2020


Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer.

Soto-Perez-de-Celis, Enrique; (...); Battisti, Nicolo Matteo Luca

Article. 10.1016/j.jgo.2022.07.005. 2022


Campos de estudio

Compartir